https://simplecast.com Investigating HLH Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives. 2023 Sobi Inc. en Tue, 23 Sep 2025 04:00:00 +0000 Tue, 23 Sep 2025 04:00:14 +0000 https://investigating-hlh.simplecast.com Investigating HLH https://image.simplecastcdn.com/images/28a945fd-e1b5-4c16-b0ea-459c23b33a88/6d988ca5-2e09-4b1e-9526-a4c6be57ce4b/3000x3000/podcast-album-cover-for-amazelabs-3000x3000.jpg?aid=rss_feed https://investigating-hlh.simplecast.com episodic Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives. Sobi Inc. false https://feeds.simplecast.com/HCYrlxBB sobi inc. Sobi Inc. stories@amazemedialabs.com 7c0f5730-8847-4476-a604-ecd6f5a5fa6d What is MAS? In this episode of Investigating HLH, Adam Narloch speaks with Dr  Daniella Schwartz and Dr Randy Cron to discuss a rare, potentially fatal syndrome characterized  by hyperinflammation⎯macrophage activation syndrome (MAS). Dr Daniella Schwartz is a rheumatologist in Pittsburgh, Pennsylvania, and is affiliated with the University of Pittsburgh  Medical Center (UPMC) Presbyterian Shadyside and the UPMC Magee-Womens Hospital. Dr  Randy Cron is a pediatric rheumatologist at Children’s Hospital of Alabama at the University of  Alabama (UAB). Hear from these 2 experts about MAS⎯a subtype of hemophagocytic lymphohistiocytosis (HLH) that can occur in rheumatic diseases such as SAll's disease, including  systemic juvenile idiopathic arthritis (sJIA).

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Tue, 23 Sep 2025 04:00:00 +0000 stories@amazemedialabs.com (Dr. Daniella Schwartz, Dr. Randy Cron, Adam Narloch) https://investigating-hlh.simplecast.com/episodes/what-is-mas-QcI03qv3 In this episode of Investigating HLH, Adam Narloch speaks with Dr  Daniella Schwartz and Dr Randy Cron to discuss a rare, potentially fatal syndrome characterized  by hyperinflammation⎯macrophage activation syndrome (MAS). Dr Daniella Schwartz is a rheumatologist in Pittsburgh, Pennsylvania, and is affiliated with the University of Pittsburgh  Medical Center (UPMC) Presbyterian Shadyside and the UPMC Magee-Womens Hospital. Dr  Randy Cron is a pediatric rheumatologist at Children’s Hospital of Alabama at the University of  Alabama (UAB). Hear from these 2 experts about MAS⎯a subtype of hemophagocytic lymphohistiocytosis (HLH) that can occur in rheumatic diseases such as SAll's disease, including  systemic juvenile idiopathic arthritis (sJIA).

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> What is MAS? Dr. Daniella Schwartz, Dr. Randy Cron, Adam Narloch 00:29:31 Adam Narloch speaks with Dr. Daniella Schwartz and Dr. Randy Cron about recognizing and managing MAS, a rare subtype of HLH in rheumatic diseases. Adam Narloch speaks with Dr. Daniella Schwartz and Dr. Randy Cron about recognizing and managing MAS, a rare subtype of HLH in rheumatic diseases. false full 1 2 3bb78659-b6a5-43ae-a315-00dbd5249fc9 Monitoring Treatment Response Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Tue, 25 Feb 2025 05:00:00 +0000 stories@amazemedialabs.com (Kari Magee, Dr Bethany Verkamp) https://investigating-hlh.simplecast.com/episodes/monitoring-treatment-response-Z5mqG9p9 Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Monitoring Treatment Response Kari Magee, Dr Bethany Verkamp 00:15:53 Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH). Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH). false full 4 1 3ab60d5c-ccd4-4c8c-87c6-902e97ce33d8 Treating HLH Adam Narloch is joined by Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña for a discussion about treating patients with HLH. Dr Kaviany is a pediatric hematologist-oncologist and an assistant professor of pediatrics at University of Chicago Medicine. Dr Saldaña is also a pediatric hematologist-oncologist and an associate professor of pediatrics at George Washington University. Hear from these 2 experts about the overall treatment goals and strategies for patients with HLH.

Follow Us

Presented by Sobi Inc.

www.sobi.com

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 5 Jun 2024 04:00:00 +0000 stories@amazemedialabs.com (Adam Narloch, Saara Kaviany, Blachy J. Dávila Saldaña) https://investigating-hlh.simplecast.com/episodes/treating-hlh-OQMAoQrW Adam Narloch is joined by Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña for a discussion about treating patients with HLH. Dr Kaviany is a pediatric hematologist-oncologist and an assistant professor of pediatrics at University of Chicago Medicine. Dr Saldaña is also a pediatric hematologist-oncologist and an associate professor of pediatrics at George Washington University. Hear from these 2 experts about the overall treatment goals and strategies for patients with HLH.

Follow Us

Presented by Sobi Inc.

www.sobi.com

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Treating HLH Adam Narloch, Saara Kaviany, Blachy J. Dávila Saldaña 00:35:38 Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña discuss the overall treatment goals and strategies for patients with HLH. Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña discuss the overall treatment goals and strategies for patients with HLH. false full 3 1 e1773aca-9e4f-46af-84e4-1808bb488e1f Diagnosing HLH Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing HLH. Dr Kumar is a pediatric hematologist- oncologist, and a director of the Histiocytosis Center at Cincinnati Children's Hospital. Dr Scott Canna is a pediatric rheumatologist and an Assistant Professor of Pediatrics at Children’s Hospital of Philadelphia. Hear from these 2 experts about why a prompt diagnosis is critical for patients with HLH—and why it can be so difficult to achieve.

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 15 May 2024 04:00:00 +0000 stories@amazemedialabs.com (Adam Narloch, Ashish Kumar, Scott Canna) https://investigating-hlh.simplecast.com/episodes/diagnosing-hlh-oczCwjrp Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing HLH. Dr Kumar is a pediatric hematologist- oncologist, and a director of the Histiocytosis Center at Cincinnati Children's Hospital. Dr Scott Canna is a pediatric rheumatologist and an Assistant Professor of Pediatrics at Children’s Hospital of Philadelphia. Hear from these 2 experts about why a prompt diagnosis is critical for patients with HLH—and why it can be so difficult to achieve.

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Diagnosing HLH Adam Narloch, Ashish Kumar, Scott Canna 00:53:00 Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing HLH. Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing HLH. false full 2 1 6189a869-08ba-47da-8df5-af96d17d734b Introduction to HLH Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of HLH and advances in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Mon, 22 Apr 2024 04:00:00 +0000 stories@amazemedialabs.com (Adam Narloch, Michelle Hermiston) https://investigating-hlh.simplecast.com/episodes/introduction-to-hlh-bu4exrhl-cXX__diB Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of HLH and advances in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Introduction to HLH Adam Narloch, Michelle Hermiston 00:23:00 Adam Narloch speaks with Dr. Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Adam Narloch speaks with Dr. Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. false full 1 1 90358bb2-12c9-4fa2-b178-341d3ce3118b An Introduction to HLH In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Tue, 14 Nov 2023 18:22:35 +0000 stories@amazemedialabs.com (Adam Narloch, Dr Michelle Hermiston) https://investigating-hlh.simplecast.com/episodes/introduction-to-hlh-nO50NkFJ In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!

Follow Us

Presented by Sobi Inc.

https://www.sobi.com/usa/en

©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> An Introduction to HLH Adam Narloch, Dr Michelle Hermiston 00:00:41 Join us with Dr Michelle Hermiston to discuss the history of hemophagocytic lymphohistiocytosis (HLH) and advances in our knowledge of this rare disease. Join us with Dr Michelle Hermiston to discuss the history of hemophagocytic lymphohistiocytosis (HLH) and advances in our knowledge of this rare disease. false trailer 1